Prof. Illana Gozes

Prof. Illana Gozes, the Lily and Avraham Gildor Chair for the Investigation of Growth factors at Tel Aviv University. At the Sackler Faculty of Medicine, Professor Gozes heads the Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology (including ~10 staff members), at the Department of Human Molecular Genetics and Biochemistry also affiliated with Sagol School of Neuroscience and the Adams Super Center for Brain Studies. 

Professor Gozes Illana Gozes,Tel Aviv University, is the Editor-in Chief of the Journal of Molecular Neuroscience. Among others, Prof. Gozes heads the Tel Aviv Chapter of the Society for Neuroscience, is an Associate Editor on the Journal of Alzheimer's Disease and member of the Editorial Advisory Panel and Editorial Board of Scientific Reports (Nature), an Ex-President of the Israel Society for Neuroscience (ISFN) and Past Director of the Adams Super Center for Brain Studies. Professor Gozes was the Founding Scientist and a Director at Allon Therapeutics Inc., Vancouver, Canada and is currently the Chief Scientific Officer of Coronis Neurosciences. Professor Gozes (BSc, Tel Aviv University, PhD, Weizmann Institute of Science, postdoctoral fellow at Massachusetts Institute of Technology (MIT), research associate/visiting scientist, Salk Institute and the Scripps Clinic and Research Foundation) was a Senior Scientist/Associate Professor at the Weizmann Institute and a Fogarty Scholar – in – Residence at the National Institutes of Health (NIH, USA). Prof. Gozes has published >300 papers, in the fields of neuroscience and is cited >13000 times (H index 62). Professor Gozes received many prizes (including the Teva award, the Landau Prize, the Humboldt Award and the Champion of Hope Award) for her pioneering work on nervous system function, from genes to behavior and drug development for the ADNP syndrome. Some of her propriety inventions are in clinical development (e.g. CP201 – orphan drug status for the ADNP syndrome).